{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:59:02Z","timestamp":1780581542664,"version":"3.54.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/jcp.0b013e3182970431","type":"journal-article","created":{"date-parts":[[2013,6,15]],"date-time":"2013-06-15T11:05:57Z","timestamp":1371294357000},"page":"538-541","source":"Crossref","is-referenced-by-count":33,"title":["Effect of the Addition of Aripiprazole on Hyperprolactinemia Associated With Risperidone Long-Acting Injection"],"prefix":"10.1097","volume":"33","author":[{"given":"Mehdi","family":"Ziadi Trives","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Mar\u00eda","family":"Bonete Ll\u00e1cer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel-Alfonso","family":"Garc\u00eda Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Jerem\u00edas","family":"Mart\u00ednez Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"4","key":"R2-15-20210128","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0022-5347(17)38964-4","article-title":"Hyperprolactinemia and impotence: why, when and how to investigate.","volume":"142","author":"Leonard","year":"1989","journal-title":"J Urol"},{"issue":"suppl 2","key":"R3-15-20210128","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.euroneuro.2008.02.004","article-title":"Prolactin awareness: an essential consideration for physical health in schizophrenia.","volume":"18","author":"Montejo","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"issue":"438","key":"R4-15-20210128","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0447.2008.01310.x","article-title":"Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.","author":"Bebbington","year":"2009","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"10","key":"R5-15-20210128","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1111\/j.1743-6109.2010.01709.x","article-title":"Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics.","volume":"7","author":"Montejo","year":"2010","journal-title":"J Sex Med"},{"key":"R8-15-20210128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/00926230600666378","article-title":"A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning.","volume":"32","author":"Knegtering","year":"2006","journal-title":"J Sex Marital Ther"},{"issue":"7","key":"R9-15-20210128","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/0269881107078281","article-title":"Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.","volume":"21","author":"Bushe","year":"2007","journal-title":"J Psychopharmacol"},{"issue":"3","key":"R10-15-20210128","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/jpet.102.035303","article-title":"The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats.","volume":"302","author":"Kapur","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"R11-15-20210128","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/oxfordjournals.schbul.a007130","article-title":"Sexuality and schizophrenia: a review.","volume":"30","author":"Kelly","year":"2004","journal-title":"Schizophr Bull"},{"issue":"2","key":"R12-15-20210128","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.pra.0000265771.47153.a0","article-title":"Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.","volume":"13","author":"Freeman","year":"2007","journal-title":"J Psychiatr Pract"},{"issue":"3","key":"R13-15-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/cap.2006.16.317","article-title":"The effect of long-term antipsychotic treatment on prolactin.","volume":"16","author":"Staller","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8","key":"R14-15-20210128","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"R15-15-20210128","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","article-title":"Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.","volume":"26","author":"DeLeon","year":"2004","journal-title":"Clin Ther"},{"issue":"2","key":"R16-15-20210128","first-page":"CD004578","article-title":"Aripiprazole for schizophrenia.","author":"El-Sayeh","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"R17-15-20210128","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14656566.3.10.1381","article-title":"Antipsychotics: impact on prolactin levels.","volume":"3","author":"Goodnick","year":"2002","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"R18-15-20210128","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/jcp.0b013e31815ac4e5","article-title":"Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.","volume":"27","author":"Byerly","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"R19-15-20210128","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4088\/JCP.v63n0903","article-title":"Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.","volume":"63","author":"Kane","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R20-15-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-244X-8-95","article-title":"The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).","volume":"8","author":"Hanssens","year":"2008","journal-title":"BMC Psychiatry"},{"issue":"3","key":"R21-15-20210128","first-page":"141","article-title":"Propiedades psicometricas del cuestionario de disfuncion sexual secuandaria a farmacos.","volume":"28","author":"Montejo","year":"2000","journal-title":"Actas Esp Psiquiatr"},{"key":"R22-15-20210128","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale.","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"issue":"26","key":"R23-15-20210128","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJM198012253032605","article-title":"Decreased bone density in hyperprolactinemic women.","volume":"303","author":"Klibanski","year":"1980","journal-title":"N Engl J Med"},{"issue":"12","key":"R24-15-20210128","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.2006.07.6356","article-title":"A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.","volume":"25","author":"Tworoger","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1-3","key":"R25-15-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.schres.2009.07.012","article-title":"Schizophrenia and breast cancer incidence: a systematic review of clinical studies.","volume":"114","author":"Bushe","year":"2009","journal-title":"Schizophr Res"},{"issue":"1","key":"R26-15-20210128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beem.2005.09.008","article-title":"Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health.","volume":"20","author":"Harvey","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"R27-15-20210128","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1191\/0960327106ht643oa","article-title":"Hyperprolactinaemia as an adverse effect in regulatory and clinical toxicology: role in breast and prostate cancer.","volume":"25","author":"Harvey","year":"2006","journal-title":"Hum Exp Toxicol"},{"issue":"10","key":"R29-15-20210128","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archpsyc.60.10.974","article-title":"Mechanism of new antipsychotic medications: occupancy is not just antagonism.","volume":"60","author":"Grunder","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"R30-15-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/appi.psy.50.4.317","article-title":"Evidence for the partial dopamine-receptor agonist aripiprazole as a first-line treatment of psychosis in patients with iatrogenic or tumorigenic hyperprolactinemia.","volume":"50","author":"Hoffer","year":"2009","journal-title":"Psychosomatics"},{"issue":"1","key":"R31-15-20210128","first-page":"13","article-title":"Observational, open-label, prospective multicentre study of sexual function in patients starting treatment with aripiprazole.","volume":"38","author":"Montejo","year":"2010","journal-title":"Actas Esp Psiquiatr"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182970431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:01:46Z","timestamp":1620957706000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201308000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182970431","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}